NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Panacea

Panacea

Private
—FinTechhttps://withpanacea.com/

Last Round

Series B

Extension

Jul 14, 2025

Est. Valuation

$105.26M

Total Funding Raised

$61.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Panacea is a healthcare technology company that provides AI-native FDA regulatory services by pairing expert consultants with an AI platform to accelerate the approval process for biotech and medtech companies.

Sector

FinTech

Verticals

Lending & Credit, Digital Banking

Business Model

B2C

Customer Profile

Payment Processing Fee, Services & Consulting

AI Layer

Application

Keywords

neobankbanking for doctorsphysician loansstudent loan refinancepractice loansdigital bankingmedical practice financingdoctor mortgagesniche bankingfinancial services for doctorsmerchant servicescontract review

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Panacea Comparables

Compare Panacea with similar companies based on industry and business-model similarity.

Panacea comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Panacea Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJul 14, 2025
Series BJan 16, 2024
View all Funding Rounds

Panacea Investors

Notable investors and investment history

Panacea investors
InvestorRounds
Valar VenturesSeries B Extension, Series B
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 14, 2025

    $37M round led by Valar Ventures.

  • Jan 16, 2024

    $25M round led by Valar Ventures

View all signals

Panacea Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Panacea Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Panacea's valuation, stock price, and market status.

Firmographic Details

Headquarters—
Year Founded2024
Last FundingJul 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.